THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS

Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major por...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacological research 1997-07, Vol.36 (1), p.9-15
Hauptverfasser: SÜ ZER, Ö NER, Dİ Rİ, ERDAL, KONUKOĞ LU, Dİ LDAR, Ö ZÜ NER, ZEKİ
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 15
container_issue 1
container_start_page 9
container_title Pharmacological research
container_volume 36
creator SÜ ZER, Ö NER
Dİ Rİ, ERDAL
KONUKOĞ LU, Dİ LDAR
Ö ZÜ NER, ZEKİ
description Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major portion of this study. Selecting the best method among those used for cardioprotection is still been debated. This experimental study investigated whether isocolloidoosmotic solution in addition to St. Thomas Hospital cardioplegic solution would give better cardioprotection. Wistar rat hearts were isolated and perfused by the Langendorff method (n=6 for each group). In the control group after stabilisation, the hearts were arrested while perfused with St. Thomas Hospital cardioplegic solution for 3 min, then they were placed in cardioplegic solution at 4°C for 6 h. Afterwards the hearts were reperfused. In the experimental groups, modified gelatin fluid (30 g/l) or HES 200/0.5 (50 g/l) or dextran 70 (25 g/l) was added to the cardioplegic solution. Maximum contractility, +dF/dtmax, −dF/dtmax, heart rate, contractility rate product, coronary flow and lactate dehydrogenase, creatine phosphokinase enzyme leakage were measured in all groups during pre-ischemic and post-ischemic periods (10 min after reperfusion). At the end of each experiment, the hearts were weighted and tissue levels of lipid peroxide, expressed in terms of thiobarbituric acid reactive substances, malondialdehyde, glutathione (an important intracellular antioxidant) and ATP were measured. Non-ischemic tissue levels of malondialdehyde, glutathione and ATP were also measured in another group (n=6). There was no statistically significant difference among the simultaneous experimental and control groups in any criteria evaluated (P>0.05). The addition of synthetic colloids to the standard cardioplegic solution did not provide further protection except for the gelatin group in which recovered contractile force was not significantly different from the group's initial values. This effect may be explained by its degradation to amino acids which may play a substrate role.
doi_str_mv 10.1006/phrs.1997.0206
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79423345</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661897902061</els_id><sourcerecordid>79423345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-5237233cefc4d8f1e8ab50a6850440ddd6acfc441f748317507b41536421989c3</originalsourceid><addsrcrecordid>eNp1kcFv2yAYxdG0qevaXXubxGk3exAwhqNlO7MlGiKbHHpCDsaqp6TJTFJpf8v-2eEm220nnnjv-32CB8ADRjFGiH07Pk8-xkKkMVog9g7cYiRYhDFn72dNScQY5h_BJ-9_IIQExegG3AjCuEDiFvzWVQkbJUuolrBuVa6kVHWhVPuodJ3D9mkVErO6OjArilrXagW1gq2Ooa7UY9bCSrXrWmcS5llT1Goty-_zuJKbt_BSNX-dRukyf7usV_NKmemygOuyWW7aIJpMw6rMGt3egw9Dt_Pu8_W8A5tlqfMqkiqwMxlZQsQpShYkXRBi3WBpzwfseLdNUMd4gihFfd-zzgaL4iGlnOA0QemW4oQwusCCC0vuwNcL9zgdfp6dP5n96K3b7boXdzh7kwoa-DQJwfgStNPB-8kN5jiN-276ZTAycxtmbsPMbZi5jTDw5Uo-b_eu_xe_fn_w-cV34Xmvo5uMt6N7sa4fJ2dPpj-M_0P_AXvCjMk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79423345</pqid></control><display><type>article</type><title>THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>SÜ ZER, Ö NER ; Dİ Rİ, ERDAL ; KONUKOĞ LU, Dİ LDAR ; Ö ZÜ NER, ZEKİ</creator><creatorcontrib>SÜ ZER, Ö NER ; Dİ Rİ, ERDAL ; KONUKOĞ LU, Dİ LDAR ; Ö ZÜ NER, ZEKİ</creatorcontrib><description>Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major portion of this study. Selecting the best method among those used for cardioprotection is still been debated. This experimental study investigated whether isocolloidoosmotic solution in addition to St. Thomas Hospital cardioplegic solution would give better cardioprotection. Wistar rat hearts were isolated and perfused by the Langendorff method (n=6 for each group). In the control group after stabilisation, the hearts were arrested while perfused with St. Thomas Hospital cardioplegic solution for 3 min, then they were placed in cardioplegic solution at 4°C for 6 h. Afterwards the hearts were reperfused. In the experimental groups, modified gelatin fluid (30 g/l) or HES 200/0.5 (50 g/l) or dextran 70 (25 g/l) was added to the cardioplegic solution. Maximum contractility, +dF/dtmax, −dF/dtmax, heart rate, contractility rate product, coronary flow and lactate dehydrogenase, creatine phosphokinase enzyme leakage were measured in all groups during pre-ischemic and post-ischemic periods (10 min after reperfusion). At the end of each experiment, the hearts were weighted and tissue levels of lipid peroxide, expressed in terms of thiobarbituric acid reactive substances, malondialdehyde, glutathione (an important intracellular antioxidant) and ATP were measured. Non-ischemic tissue levels of malondialdehyde, glutathione and ATP were also measured in another group (n=6). There was no statistically significant difference among the simultaneous experimental and control groups in any criteria evaluated (P&gt;0.05). The addition of synthetic colloids to the standard cardioplegic solution did not provide further protection except for the gelatin group in which recovered contractile force was not significantly different from the group's initial values. This effect may be explained by its degradation to amino acids which may play a substrate role.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1006/phrs.1997.0206</identifier><identifier>PMID: 9368909</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adenosine Triphosphate - metabolism ; Animals ; Bicarbonates - pharmacology ; Calcium Chloride - pharmacology ; cardiac protection ; cardioplegic solution ; Cardioplegic Solutions - pharmacology ; Colloids ; Coronary Circulation - drug effects ; Creatine Kinase - metabolism ; dextrans ; Female ; Gelatin ; gelatins ; Glutathione - metabolism ; Heart ; HES ; In Vitro Techniques ; L-Lactate Dehydrogenase - metabolism ; Magnesium - pharmacology ; Male ; Malondialdehyde - metabolism ; Myocardial Contraction - drug effects ; Myocardial Ischemia - metabolism ; Myocardial Reperfusion ; Myocardium - enzymology ; Myocardium - metabolism ; Organ Preservation - methods ; Potassium Chloride - pharmacology ; Rats ; Rats, Wistar ; Sodium Chloride - pharmacology ; St Thomas Hospital</subject><ispartof>Pharmacological research, 1997-07, Vol.36 (1), p.9-15</ispartof><rights>1997 The Italian Pharmacological Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-5237233cefc4d8f1e8ab50a6850440ddd6acfc441f748317507b41536421989c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/phrs.1997.0206$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9368909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SÜ ZER, Ö NER</creatorcontrib><creatorcontrib>Dİ Rİ, ERDAL</creatorcontrib><creatorcontrib>KONUKOĞ LU, Dİ LDAR</creatorcontrib><creatorcontrib>Ö ZÜ NER, ZEKİ</creatorcontrib><title>THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major portion of this study. Selecting the best method among those used for cardioprotection is still been debated. This experimental study investigated whether isocolloidoosmotic solution in addition to St. Thomas Hospital cardioplegic solution would give better cardioprotection. Wistar rat hearts were isolated and perfused by the Langendorff method (n=6 for each group). In the control group after stabilisation, the hearts were arrested while perfused with St. Thomas Hospital cardioplegic solution for 3 min, then they were placed in cardioplegic solution at 4°C for 6 h. Afterwards the hearts were reperfused. In the experimental groups, modified gelatin fluid (30 g/l) or HES 200/0.5 (50 g/l) or dextran 70 (25 g/l) was added to the cardioplegic solution. Maximum contractility, +dF/dtmax, −dF/dtmax, heart rate, contractility rate product, coronary flow and lactate dehydrogenase, creatine phosphokinase enzyme leakage were measured in all groups during pre-ischemic and post-ischemic periods (10 min after reperfusion). At the end of each experiment, the hearts were weighted and tissue levels of lipid peroxide, expressed in terms of thiobarbituric acid reactive substances, malondialdehyde, glutathione (an important intracellular antioxidant) and ATP were measured. Non-ischemic tissue levels of malondialdehyde, glutathione and ATP were also measured in another group (n=6). There was no statistically significant difference among the simultaneous experimental and control groups in any criteria evaluated (P&gt;0.05). The addition of synthetic colloids to the standard cardioplegic solution did not provide further protection except for the gelatin group in which recovered contractile force was not significantly different from the group's initial values. This effect may be explained by its degradation to amino acids which may play a substrate role.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Animals</subject><subject>Bicarbonates - pharmacology</subject><subject>Calcium Chloride - pharmacology</subject><subject>cardiac protection</subject><subject>cardioplegic solution</subject><subject>Cardioplegic Solutions - pharmacology</subject><subject>Colloids</subject><subject>Coronary Circulation - drug effects</subject><subject>Creatine Kinase - metabolism</subject><subject>dextrans</subject><subject>Female</subject><subject>Gelatin</subject><subject>gelatins</subject><subject>Glutathione - metabolism</subject><subject>Heart</subject><subject>HES</subject><subject>In Vitro Techniques</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>Magnesium - pharmacology</subject><subject>Male</subject><subject>Malondialdehyde - metabolism</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocardial Ischemia - metabolism</subject><subject>Myocardial Reperfusion</subject><subject>Myocardium - enzymology</subject><subject>Myocardium - metabolism</subject><subject>Organ Preservation - methods</subject><subject>Potassium Chloride - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Sodium Chloride - pharmacology</subject><subject>St Thomas Hospital</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcFv2yAYxdG0qevaXXubxGk3exAwhqNlO7MlGiKbHHpCDsaqp6TJTFJpf8v-2eEm220nnnjv-32CB8ADRjFGiH07Pk8-xkKkMVog9g7cYiRYhDFn72dNScQY5h_BJ-9_IIQExegG3AjCuEDiFvzWVQkbJUuolrBuVa6kVHWhVPuodJ3D9mkVErO6OjArilrXagW1gq2Ooa7UY9bCSrXrWmcS5llT1Goty-_zuJKbt_BSNX-dRukyf7usV_NKmemygOuyWW7aIJpMw6rMGt3egw9Dt_Pu8_W8A5tlqfMqkiqwMxlZQsQpShYkXRBi3WBpzwfseLdNUMd4gihFfd-zzgaL4iGlnOA0QemW4oQwusCCC0vuwNcL9zgdfp6dP5n96K3b7boXdzh7kwoa-DQJwfgStNPB-8kN5jiN-276ZTAycxtmbsPMbZi5jTDw5Uo-b_eu_xe_fn_w-cV34Xmvo5uMt6N7sa4fJ2dPpj-M_0P_AXvCjMk</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>SÜ ZER, Ö NER</creator><creator>Dİ Rİ, ERDAL</creator><creator>KONUKOĞ LU, Dİ LDAR</creator><creator>Ö ZÜ NER, ZEKİ</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970701</creationdate><title>THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS</title><author>SÜ ZER, Ö NER ; Dİ Rİ, ERDAL ; KONUKOĞ LU, Dİ LDAR ; Ö ZÜ NER, ZEKİ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-5237233cefc4d8f1e8ab50a6850440ddd6acfc441f748317507b41536421989c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Animals</topic><topic>Bicarbonates - pharmacology</topic><topic>Calcium Chloride - pharmacology</topic><topic>cardiac protection</topic><topic>cardioplegic solution</topic><topic>Cardioplegic Solutions - pharmacology</topic><topic>Colloids</topic><topic>Coronary Circulation - drug effects</topic><topic>Creatine Kinase - metabolism</topic><topic>dextrans</topic><topic>Female</topic><topic>Gelatin</topic><topic>gelatins</topic><topic>Glutathione - metabolism</topic><topic>Heart</topic><topic>HES</topic><topic>In Vitro Techniques</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>Magnesium - pharmacology</topic><topic>Male</topic><topic>Malondialdehyde - metabolism</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocardial Ischemia - metabolism</topic><topic>Myocardial Reperfusion</topic><topic>Myocardium - enzymology</topic><topic>Myocardium - metabolism</topic><topic>Organ Preservation - methods</topic><topic>Potassium Chloride - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Sodium Chloride - pharmacology</topic><topic>St Thomas Hospital</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SÜ ZER, Ö NER</creatorcontrib><creatorcontrib>Dİ Rİ, ERDAL</creatorcontrib><creatorcontrib>KONUKOĞ LU, Dİ LDAR</creatorcontrib><creatorcontrib>Ö ZÜ NER, ZEKİ</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SÜ ZER, Ö NER</au><au>Dİ Rİ, ERDAL</au><au>KONUKOĞ LU, Dİ LDAR</au><au>Ö ZÜ NER, ZEKİ</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>1997-07-01</date><risdate>1997</risdate><volume>36</volume><issue>1</issue><spage>9</spage><epage>15</epage><pages>9-15</pages><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major portion of this study. Selecting the best method among those used for cardioprotection is still been debated. This experimental study investigated whether isocolloidoosmotic solution in addition to St. Thomas Hospital cardioplegic solution would give better cardioprotection. Wistar rat hearts were isolated and perfused by the Langendorff method (n=6 for each group). In the control group after stabilisation, the hearts were arrested while perfused with St. Thomas Hospital cardioplegic solution for 3 min, then they were placed in cardioplegic solution at 4°C for 6 h. Afterwards the hearts were reperfused. In the experimental groups, modified gelatin fluid (30 g/l) or HES 200/0.5 (50 g/l) or dextran 70 (25 g/l) was added to the cardioplegic solution. Maximum contractility, +dF/dtmax, −dF/dtmax, heart rate, contractility rate product, coronary flow and lactate dehydrogenase, creatine phosphokinase enzyme leakage were measured in all groups during pre-ischemic and post-ischemic periods (10 min after reperfusion). At the end of each experiment, the hearts were weighted and tissue levels of lipid peroxide, expressed in terms of thiobarbituric acid reactive substances, malondialdehyde, glutathione (an important intracellular antioxidant) and ATP were measured. Non-ischemic tissue levels of malondialdehyde, glutathione and ATP were also measured in another group (n=6). There was no statistically significant difference among the simultaneous experimental and control groups in any criteria evaluated (P&gt;0.05). The addition of synthetic colloids to the standard cardioplegic solution did not provide further protection except for the gelatin group in which recovered contractile force was not significantly different from the group's initial values. This effect may be explained by its degradation to amino acids which may play a substrate role.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>9368909</pmid><doi>10.1006/phrs.1997.0206</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-6618
ispartof Pharmacological research, 1997-07, Vol.36 (1), p.9-15
issn 1043-6618
1096-1186
language eng
recordid cdi_proquest_miscellaneous_79423345
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adenosine Triphosphate - metabolism
Animals
Bicarbonates - pharmacology
Calcium Chloride - pharmacology
cardiac protection
cardioplegic solution
Cardioplegic Solutions - pharmacology
Colloids
Coronary Circulation - drug effects
Creatine Kinase - metabolism
dextrans
Female
Gelatin
gelatins
Glutathione - metabolism
Heart
HES
In Vitro Techniques
L-Lactate Dehydrogenase - metabolism
Magnesium - pharmacology
Male
Malondialdehyde - metabolism
Myocardial Contraction - drug effects
Myocardial Ischemia - metabolism
Myocardial Reperfusion
Myocardium - enzymology
Myocardium - metabolism
Organ Preservation - methods
Potassium Chloride - pharmacology
Rats
Rats, Wistar
Sodium Chloride - pharmacology
St Thomas Hospital
title THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A55%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THE%20ROLE%20OF%20ISOCOLLOIDOOSMOTIC%20SYNTHETIC%20COLLOID%20ADDITION%20TO%20ST.%20THOMAS%20HOSPITAL%20CARDIOPLEGIC%20SOLUTION%20FOR%20CARDIOPROTECTION%20IN%20ISOLATED%20PERFUSED%20RAT%20HEARTS&rft.jtitle=Pharmacological%20research&rft.au=S%C3%9C%20ZER,%20%C3%96%20NER&rft.date=1997-07-01&rft.volume=36&rft.issue=1&rft.spage=9&rft.epage=15&rft.pages=9-15&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1006/phrs.1997.0206&rft_dat=%3Cproquest_cross%3E79423345%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79423345&rft_id=info:pmid/9368909&rft_els_id=S1043661897902061&rfr_iscdi=true